Trademarkia Logo

Canada

C$
FUJIREBIO DESIGN
FORMALIZED

on 4 Jul 2023

Last Applicant/ Owned by

FUJIREBIO INC.

8-1, Akasaka 1-chomeMinato-ku, Tokyo, 107-0052

JP

Serial Number

2267443 filed on 4th Jul 2023

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

CA

H3B1R1

FUJIREBIO DESIGN

Trademark usage description

diagnostic enzymes for in vitro use in biochemistry; diagnostic enzymes for in vitro use in clinical chemistry; diagnostic enzymes for in vitro use in Read More

Classification Information


Class [001]
Diagnostic enzymes for in vitro use in biochemistry; diagnostic enzymes for in vitro use in clinical chemistry; diagnostic enzymes for in vitro use in microbiology; laboratory assay kits; biological assays and kits for use in fields of biological and diagnostic testing for industrial, scientific and research use; diagnostic reagents for medical-scientific research use; antibody reagents for scientific purposes; diagnostic preparations for in vitro testing for scientific use; diagnostic preparations for medical-scientific research use; in vitro diagnostic reagents for scientific purposes; cell culture reagents for scientific or research purposes; biochemical catalysts; chemical reagents for use in genetic research; diagnostic reagents for in vitro use in chemical analysis; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; cell culture reagents for laboratory use; chemical reagents for use in nucleic acid isolation and purification; chemical additives for use in the manufacture of medicines; reagents for testing the sterility of pharmaceuticals and injectable solutions.


Classification kind code

12

Mark Details


Serial Number

2267443

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 135
on 5th Jan 2024
Amendment to Application
Submitted for opposition 287
on 20th Jul 2023
Pre-Assessment Letter Sent
Submitted for opposition 30
on 4th Jul 2023
Filed
Submitted for opposition 1
on 4th Jul 2023
Created
Submitted for opposition 31
on 4th Jul 2023
Formalized